Speaker: Dr Christina Bursill, National Heart Foundation Lin Huddleston Research Fellow, University of Adelaide Faculty of Health and Medical Sciences and Heart Health Theme SAHMRI
Title: Understanding the pathway to translation for high-density lipoproteins (HDL) – Characterisation of the different vascular biological mechanisms of HDL in atherosclerosis and angiogenesis
Chair: Dr Prue Cowled, Principal Medical Scientist, Discipline of Surgery, University of Adelaide and Basil Hetzel Institute, TQEH. Located Level 2 BHI. [email protected]
Speaker biography: Dr Christina Bursill recently commenced as co-Director of the Vascular Research Centre at the South Australian Health and Medical Research Institute in January 2017 and as a Senior Research Fellow at The University of Adelaide, Faculty of Health and Medical Sciences. She currently holds the Lin Huddleston National Heart Foundation fellowship. Dr Bursill is a vascular biologist with interests and expertise in vascular inflammation, atherosclerosis and angiogenesis. She completed her PhD at the University of Adelaide in lipid metabolism then headed to Oxford University for five years to undergo a postdoctoral post in the Departments of Cardiovascular Medicine and Pathology. Her postdoctoral time triggered her interest in the mechanisms that cause atherosclerosis and in particular the role of small inflammatory proteins called Chemokines. Christina returned to Australia in 2007 at the Heart Research Institute (HRI) in Sydney where she led the Immunobiology Group. As part of her National Heart Foundation Career Development Fellowship and through NHF/NHMRC funding, Dr Bursill investigated novel actions and mechanisms of high-density lipoproteins (HDL) in models of stent biocompatibility, diabetes and wound healing. She also has an interest in using viral gene transfer techniques to over-express proteins that attenuate chemokine activity to suppress inflammatory-driven diseases.